The May TB Journal Club takes place *tomorrow* Thursday 29th, 4pm UK time. Liv-TB will be taking us through tinyurl.com/vn7995ke trial of pyrazinamide dosing, safety & efficacy. Look forward to seeing you there! #tuberculosis #TB

#Tuberculosis Journal Club **TODAY** 4pm UK time. @jaseddon.bsky.social & Dr Amedine Duret taking us through the drivers of adolescent TB 👫 pmc.ncbi.nlm.nih.gov/articles/PMC... by Silvia Chiang, @petedodd24.bsky.social &al Hope to see you there! eepurl.com/hO4D79 to join mailing list ✉️ #tbsky

Factors driving adolescent tuberculosis incidence by age and sex in 30 high-tuberculosis burden countries: a mathematical modelling study

During adolescence, tuberculosis incidence rises, with a greater increase in males compared with females. Tuberculosis notifications and estimates infrequently disaggregate adolescent age groups. More...

pmc.ncbi.nlm.nih.gov

Kicking off #TB #JournalClub 2025 with great discussion of shorturl.at/AGD8l Duong &al 2024 meta-analysis of VQUIN & TB-CHAMP RCTs. In our closing poll, 54% of audience members would take levo TPT if their household contact had quinolone-sensitive #DRTB - the rest chose another regimen/no TPT #tbsky

First TB Journal Club of 2025 meets *this Thursday* 20th at 4pm UK time 🕓 Liz Corbett & Verena Faehling @lshtm.bsky.social will be discussing shorturl.at/AGD8l Duong &al 2024 meta-analysis of VQUIN & TB-CHAMP RCTs of levofloxacin for #MDRTB contacts. Hope to see you there! #tbsky #tuberculosis

A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis

Data from randomized trials evaluating the effectiveness of tuberculosis (TB) preventive treatment for contacts of multidrug-resistant (MDR)-TB are lacking. Two recently published randomized trials...

shorturl.at

REMINDER - final TBJC of 2024 is tomorrow at 4pm UK time. Look forward to seeing you there! #tuberculosis #journalclub

TB Journal Club@tbjournalclub.bsky.social · 2y ago

❗Final #TBJC of 2024 🕓Thurs November 28, 4pm UK 🏛️Hosts: SGUL. Chair: Sean Wasserman. Presenter: Sharenja Ratnakumar. 💊 shorturl.at/jcijg long-term efficacy & safety from STREAM2 trial of shorter regimens for #DRTB ✉️ eepurl.com/hO4D79 to join mailing list for monthly #tuberculosis journal clubs!

❗Final #TBJC of 2024 🕓Thurs November 28, 4pm UK 🏛️Hosts: SGUL. Chair: Sean Wasserman. Presenter: Sharenja Ratnakumar. 💊 shorturl.at/jcijg long-term efficacy & safety from STREAM2 trial of shorter regimens for #DRTB ✉️ eepurl.com/hO4D79 to join mailing list for monthly #tuberculosis journal clubs!

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, ...

Both of the bedaquiline-containing regimens maintained superiority to the control regimen, without evidence of increased mortality, providing two additional evidence-based treatment options for patien...

shorturl.at

We host monthly online international journal clubs on the latest #tuberculosis literature. We welcome researchers, clinicians, and anyone else interested in #TB - eepurl.com/hO4D79 to join the mailing list & hear about future meetings.